DOLUTEGRAVIR SODIUM by Cipla is hiv-1 antiretroviral agent [see microbiology ( )]. Approved for combination with rilpivirine, known substitutions associated with resistance to either antiretroviral agent, combination with other antiretroviral agents for the treatment of hiv-1 infection in adults (treatment-naïve and 3 more indications.
Drug data last refreshed 4h ago
HIV-1 antiretroviral agent [see Microbiology ( )].
Worked on DOLUTEGRAVIR SODIUM at Cipla? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.